Here's the Final Tally on How Much Money Trump Raised for Hurricane Victims
WATCH: California's Harsher Criminal Penalties Are Working
Here's the Latest on That University of Oregon Employee Who Said Trump Supporters...
Watch an Eagles Fan 'Crash' a New York Giants Fan's Event...and the Reaction...
We Almost Had Another Friendly Fire Incident
Not Quite As Crusty As Biden Yet
Legal Group Puts Sanctuary Jurisdictions on Notice Ahead of Trump's Mass Deportation Opera...
The International Criminal Court Pretends to Be About Justice
The Best Christmas Gift of All: Trump Saved The United States of America
Who Can Trust White House Reporters Who Hid Biden's Infirmity?
The Debt This Congress Leaves Behind
How Cops, Politicians and Bureaucrats Tried to Dodge Responsibility in 2024
Meet the Worst of the Worst Biden Just Spared From Execution
Celebrating the Miracle of Light
Chimney Rock Demonstrates Why America Must Stay United
Tipsheet

Rand Paul Corners Fauci on Quietly Changing Gain-of-Function Definition

AP Photo/J. Scott Applewhite, Pool

Dr. Anthony Fauci is back on Capitol Hill Thursday for questioning in front of the Senate Health Committee. 

Under questioning from Dr. Rand Paul, Fauci again attempted to redefine the meaning of gain-of-function research. 

Advertisement

Fauci has repeatedly denied his agency funded dangerous gain-of-function research at the Wuhan Institute of Virology. Recently, the National Institute of Health disputed that claim

"The fifth and final progress report for Grant R01AI110964, awarded to EcoHealth Alliance, Inc. is attached with redactions only for personally identifiable information," NIH Principal Deputy Director Larence Tabak explained in a letter to Republican Congressman James Comer. "It includes data from a research project conducted during the 2018-2019 grant period using bat coronavirus genome sequences already existing in nature."

Advertisement

"The limited experiment described the final progress report provided by EcoHealth Alliance was testing if spike proteins from naturally occurring bat coronaviruses circulating in China were capable of biding to the human ACE2 receptor in a mouse model," the letter continues. "In this limited experiment, laboratory mice infected with the SHC014 W1V1 bat coronavirus became sicker than those infected with the W1V1 bat coronavirus."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement